Earnings Ahead

BIIB - Biogen Inc

146.235 1.825 1.26

Biogen Inc

Biogen Inc

About

Profile

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies


Headquarters

Cambridge, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

BIIB



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Biogen swings to Q3 growth after Reata acquisition (update)
  • Biogen Non-GAAP EPS of $4.36 beats by $0.37, revenue of $2.53B beats by $130M
  • Biogen Q3 2023 Earnings Preview
  • Sage Therapeutics falls after stock offering, Q3 miss
  • Eisai sees a sharp rise in patients on Biogen-partnered Alzheimer’s drug
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Catalyst Watch: Disney earnings, Moderna AI event, Powell IMF speech and Las Vegas strike threat
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • Biogen says new Leqembi formulation better than IV version
  • Biogen updates Phase 1 data for Ionis-partnered Alzheimer’s drug
  • U.S. to expand access to PET imaging scans for Alzheimer's disease diagnosis
  • FDA approves Biogen’s biosimilar to Roche's arthritis drug Actemra
  • Biogen/ Eisai Alzheimer’s therapy Leqembi approved in Japan
  • These companies set to benefit from sales of Biogen Alzheimer's med Leqembi
  • Reata shareholders clear buyout deal with Biogen
  • Catalyst watch: Microsoft, Amazon, Oracle, and Intel to Hold High-Profile Events
  • Intas reportedly readying bid of up to $1B for Biogen biosimilars unit
  • Reata Pharmaceuticals climbs as HSR waiting period for sale to Biogen expired
  • HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead
  • Catalyst Watch: Arm IPO, Apple event, and Senate AI Forum with Musk, Zuckerberg, and Gates

Earnings History

Date EPS / Forecast Revenue / Forecast
February 3, 2022 3.39 / 3.35 2.73B / 2.62B Beat!
October 20, 2021 4.77 / 4.09 2.78B / 2.67B Beat!
July 22, 2021 5.68 / 4.55 2.78B / 2.61B Beat!
April 22, 2021 5.34 / 4.98 2.69B / 2.65B Beat!
February 3, 2021 4.58 / 4.79 2.85B / 2.8B Beat!
October 21, 2020 8.84 / 8.09 3.38B / 3.33B Beat!
July 22, 2020 10.26 / 8.02 3.68B / 3.43B Beat!
April 22, 2020 9.14 / 7.72 3.53B / 3.42B Beat!
January 30, 2020 8.34 / 8.03 3.67B / 3.54B Beat!
October 22, 2019 9.17 / 8.3 3.6B / 3.54B Beat!
July 23, 2019 9.15 / 7.53 3.62B / 3.47B Beat!
April 24, 2019 6.98 / 6.97 3.49B / 3.4B Beat!
January 29, 2019 6.99 / 6.73 3.53B / 3.39B Beat!
October 23, 2018 7.4 / 6.78 3.44B / 3.33B Beat!
July 24, 2018 5.8 / 5.21 3.36B / 3.25B Beat!
April 24, 2018 6.05 / 5.93 3.13B / 3.15B
January 25, 2018 5.26 / 5.45 3.31B / 3,080M Beat!
October 24, 2017 6.31 / 5.73 3.08B / 3,044M Beat!
July 25, 2017 5.04 / 5.62 3.08B / 2.81B Beat!
April 25, 2017 5.2 / 4.6 2.81B / - Beat!
January 26, 2017 5.04 / 5.01 2.87B / 2.94B
Date Price Open High Low Vol Change
Jan 29 144.41 145.1
147.38
143.34
1.5M -0.74%
Jan 28 145.49 148.29
148.55
145.08
1.3M -2.2%
Jan 27 148.76 146.55
149.67
146.55
1.7M 1.75%
Jan 24 146.2 143.45
146.33
141.98
1.3M 1.76%
Jan 23 143.67 143.14
143.77
139.83
1.5M 0.64%
 
Jan 22 142.75 140.75
143.15
139.71
1.1M 1.26%
Jan 21 140.98 141
142.09
140.59
1.2M 0.31%
Jan 17 140.55 143.13
143.5
140.06
1.2M -0.48%
Jan 16 141.23 140.49
142.39
140.05
1.2M 0.16%
Jan 15 141 145.46
146.15
140.87
1.6M -1.44%
Jan 14 143.06 149.92
150.22
142.42
1.7M -4.74%
Jan 13 150.18 148.92
150.48
145.82
1.1M 0.91%
Jan 10 148.82 149.18
150.2
147.65
1.3M -1.28%
Jan 8 150.75 152.27
152.82
150.07
1.0M -1.57%
Jan 7 153.15 153.11
156.37
152.9
1.1M -0.08%
Jan 6 153.27 151.93
153.6
151.62
1.3M 0.70%
Jan 3 152.21 149.73
152.97
149.73
1.2M 1.47%
Jan 2 150 153.84
154.12
149.84
1.1M -1.91%
Dec 31, 2024 152.92 150.8
153.04
150.19
1.1M 1.82%
Dec 30, 2024 150.19 150.92
151.18
148.19
1.2M -0.74%
Dec 27, 2024 151.31 148.74
151.88
148.23
1.1M 0.94%
Dec 26, 2024 149.9 148
150.68
147.83
846K 0.59%
Dec 24, 2024 149.02 148.67
149.41
147.07
525K -0.24%
Dec 23, 2024 149.38 146
149.92
145.52
1.5M 1.99%
Dec 20, 2024 146.47 145.64
147.85
145.07
5.8M -0.62%
Dec 19, 2024 147.39 146.6
148.24
145.24
1.7M 0.41%
Dec 18, 2024 146.79 150.01
151.49
146.57
1.5M -2.56%
Dec 17, 2024 150.64 150.16
154.24
149.93
1.4M 0.10%
Dec 16, 2024 150.49 149
152.25
148.6
1.9M 0.31%
Dec 13, 2024 150.03 154.57
154.57
149.93
1.6M -3.41%
Dec 12, 2024 155.33 156.7
158.2
155.21
1.1M -1.35%
Dec 11, 2024 157.46 156.37
158.15
153.68
1.4M 0.73%
Dec 10, 2024 156.32 157.34
158.1
154.99
1.9M -0.09%
Dec 9, 2024 156.46 157.21
160.74
155.75
1.5M -0.84%
Dec 6, 2024 157.78 159.06
160.83
157.35
948K -0.93%
Dec 5, 2024 159.26 161.1
162.62
158.31
1.0M -1.03%
Dec 4, 2024 160.92 160.85
161.36
159.12
1.2M 0.04%
Dec 3, 2024 160.85 162.62
163.77
160.72
1.2M -2.06%
Dec 2, 2024 164.23 160.16
165.29
160.16
1.7M 2.24%
Nov 29, 2024 160.63 160.72
161.67
158.44
1.1M 0.50%
Nov 27, 2024 159.83 158.65
160.73
158.45
1.3M 1.36%
Nov 26, 2024 157.69 159.2
160
156.09
1.4M -0.64%
Nov 25, 2024 158.71 159.99
160.63
158.35
2.1M 0.51%
Nov 22, 2024 157.9 158.1
159.72
157.28
1.7M -0.07%
Nov 21, 2024 158.01 157.17
159.1
154.74
1.9M 1.29%
Nov 20, 2024 156 155.03
156.18
153.62
1.6M 0.37%
Nov 19, 2024 155.43 157.02
157.9
155.28
1.3M -1.59%
Nov 18, 2024 157.94 158.19
160.11
157.4
1.6M -1.28%
Nov 15, 2024 159.99 165.46
166.34
159.6
1.9M -2.97%
Nov 14, 2024 164.89 165
175.86
163.35
3.2M -0.54%
Nov 13, 2024 165.79 167.74
168.98
165.53
1.4M -1.48%
Nov 12, 2024 168.28 171.36
171.61
167.71
1.4M -2.18%
Nov 11, 2024 172.03 173.92
173.92
171.11
1.5M -0.58%
Nov 8, 2024 173.04 173.58
175.2
171.57
1.6M -0.51%
Nov 7, 2024 173.92 175.69
176.95
172.8
1.4M -0.28%
Nov 6, 2024 174.4 176.87
179.2
173.66
1.8M -1.43%
Nov 5, 2024 176.93 172.71
177.25
170.72
2.5M 1.97%
Nov 4, 2024 173.52 173.22
174.85
170.71
2.5M -0.16%
Nov 1, 2024 173.79 173.65
175.99
173.14
1.5M -0.12%
Oct 31, 2024 174 178.11
179.48
173.88
1.8M 0%